NEP162
NEP162 is a BRD4 PROTAC degrader based on the E3 ubiquitin ligase GID4, with DC50 values of 1.2 μM and 1.6 μM in SW480 and U2OS cells, respectively, and a Kd value of 0.13 µM for GID4. NEP162 bridges the E3 ligase GID4 and BRD4 to form a ternary complex, promotes polyubiquitination and subsequent degradation of BRD4 via the ubiquitin-proteasome system, reduces the proliferation capacity of tumor cells and induces apoptosis. NEP162 can be used for research on cancers such as osteosarcoma, colorectal cancer and non-small cell lung cancer.
(Pink: BRD4 ligand (HY-78695); Blue: GID4 ligand (HY-D2259); Black: linker).
For research use only. We do not sell to patients.
- CAS No.: 3031840-36-2
- Formula: C50H56ClN11O3S
- Molecular Weight:926.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
BRD4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SW480 | DC50 |
1.2 μM
|
Half-maximal degradation of endogenous BRD4 in human SW480 colon cancer cells after 18 h treatment, measured via immunoblotting assay.
Half-maximal degradation of endogenous BRD4 in human SW480 colon cancer cells after 18 h treatment, measured via immunoblotting assay.
|
40295770 |
| U2OS | DC50 |
1.6 μM
|
Half-maximal degradation of endogenous BRD4 in human U2OS osteosarcoma cells after 18 h treatment, measured via immunoblotting assay.
Half-maximal degradation of endogenous BRD4 in human U2OS osteosarcoma cells after 18 h treatment, measured via immunoblotting assay.
|
40295770 |
In Vitro
NEP162 (0.1-20 μM; 6-24 h) induces dose- and time-dependent degradation of BRD4 protein in U2OS and SW480 cells, while it shows no obvious degradation effect in H3122, H520 and HEC-1-A cells[1].
NEP162 (0.5-5 μM; 24 h-7 days) inhibits cell viability, induces apoptosis, and significantly suppresses colony formation in U2OS cells[1].
NEP162 (31.25 nM-3 µM; 180 s association, 180 s dissociation) binds directly to purified recombinant GID4 protein, with a Kd value of 0.13 µM. It induces the formation of a stable ternary complex between purified recombinant GID4 and BRD4BD1 protein, with a Kd value of 0.30 µM[1].
NEP162 (2 μM; 18 h) loses its ability to degrade BRD4 protein in GID4-knockdown SW480 cells[1].
NEP162 (0.2-10 μM; 18 h) promotes the polyubiquitination of BRD4 in U2OS cells that are pre-transfected to express Flag-BRD4 and HA-Ub and pre-treated with MG132 (HY-13259), and it exerts a BRD2-degrading effect without degrading BRD3 protein[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U2OS and SW480 cells
-
Concentration:0.1, 0.2, 0.5, 1, 2, 5, 10, 20 μM
-
Incubation Time:6, 12, 18, 24 h
-
Result:Decreased endogenous BRD4 protein levels in a dose-dependent manner.
Significantly reduced BRD4 protein levels over time, especially at 18 and 24 hours.
-
Cell Line:U2OS cells
-
Concentration:0.2, 0.5, 1, 2, 5, 10 μM
-
Incubation Time:18 h
-
Result:Reduced BRD2 protein levels, but did not alter BRD3 protein expression levels.
Significantly increased the polyubiquitination levels of BRD4.
-
Cell Line:U2OS cells
-
Concentration:0.5, 2, 5 μM
-
Incubation Time:24, 48, 72 h
-
Result:Significantly inhibited cell viability and proliferation in a dose- and time-dependent manner.
-
Cell Line:U2OS cells
-
Concentration:2 μM
-
Incubation Time:24 h
-
Result:Significantly reduced the percentage of EdU-positive cells, effectively inhibiting cell proliferation.
-
Cell Line:U2OS cells
-
Concentration:2 μM
-
Incubation Time:24 h
-
Result:Significantly increased the percentage of TUNEL-positive cells, inducing tumor cell apoptosis.
-
Cell Line:U2OS cells
-
Concentration:2 μM
-
Incubation Time:7 days
-
Result:Significantly inhibited the colony-forming ability of cells and reduced the number of colonies.
-
Cell Line:U2OS cells
-
Concentration:2 μM
-
Incubation Time:18 h
-
Result:Had no significant effect on the mRNA transcription levels of BRD2, BRD3, and BRD4.
Parmacokinetics
| Species | Dose | Route | T1/2 | Tmax | Cmax | AUClast | AUCinf |
|---|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | i.p. | 1.76 h | 0.83 h | 2.68 μM | 6.68 μM·h | 6.96 μM·h |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice were injected subcutaneously with 5×106 U2OS cells[1]
-
Dosage:5 mg/kg; 10 mg/kg; 15 mg/kg
-
Administration:i.p.; every other day; 14 days
-
Result:Showed modest tumor growth inhibition at 5 mg/kg.
Notably suppressed tumor growth at 10 mg/kg and 15 mg/kg, with near-complete inhibition at 15 mg/kg.
Increased TUNEL-positive apoptotic cells and reduced Ki67-positive proliferative cells in a dose-dependent manner.
Markedly reduced BRD4 levels in tumor tissues at 10 mg/kg and 15 mg/kg.
Did not affect mouse body weight.
Showed no apparent physiological damage to vital organs via H&E staining.
Chemical Information
-
CAS No. 3031840-36-2
-
Molecular Weight 926.57
-
Formula C50H56ClN11O3S
-
SMILES
O=C(N[C@@H]1CC[C@H](C2=NC(C=CC(OCCCN3CCN(C(C[C@H]4C5=NN=C(C)N5C(SC(C)=C6C)=C6C(C7=CC=C(Cl)C=C7)=N4)=O)CC3)=C8)=C8N2)CC1)CNCC(N9)=CC%10=C9C=CC=C%10
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)